Table 1.
Characteristics of participants at baseline
| Characteristic | Statistic | Overall n = 46 | Control n = 21 | Intervention n = 25 | P-value* |
|---|---|---|---|---|---|
| Age | mean (sd) | 43.7 (13.0) | 44.8 (14.6) | 42.6 (11.0) | 0.589 |
| Sex: Male | n (%) | 16 (35%) | 9 (43%) | 7 (20%) | 0.360 |
| Medication: Yes | n (%) | 24 (52%) | 11 (52%) | 13 (52%) | 1.000 |
| Site: Northern Ireland | n (%) | 19 (41%) | 8 (38%) | 11 (44%) | 0.769 |
| Chronicity | 0.224 | ||||
| <1 year | n (%) | 1 (2%) | 0 (0%) | 1 (4%) | |
| >1 year | n (%) | 43 (93.5%) | 20 (95.2%) | 23 (92%) | |
| Not all the time | n (%) | 1 (2%) | 0 (0%) | 1 (4%) | |
| Not given | n (%) | 1 (2%) | 1 (5%) | 0 (0%) | |
| PHQ-9 | mean (sd) | 14.5 (6.5) | 14.3 (6.9) | 14.7 (6.4) | |
| GAD-7 | mean (sd) | 12.0 (5.5) | 12.8 (6.1) | 11.3 (4.9) |
*P-values from two-sample t-tests and Fisher’s tests, for continuous and categorical variables, respectively.